Diplomat Managing Rising Drug Costs to Support Patients

February 21, 2018

Responsive image

FLINT, Mich., Feb. 21, 2018 /PRNewswire/ — Diplomat Pharmacy, Inc. (NYSE: DPLO) plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications.
Joel Saban, president of Diplomat, said the growing market for high-cost…

Category: Precious Metals